UREA MOTIF CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS ANTIBACTERIAL DRUGS

(19)

(11)

EP 3 464 260 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	16.02.2022 Bulletin 2022/07

(45)	Mention of the grant of the patent:
	27.10.2021 Bulletin 2021/43

(21)	Application number: 17728481.7

(22)	Date of filing: 30.05.2017

(51)

International Patent Classification (IPC):

C07D 317/66^(2006.01)
C07C 275/34^(2006.01)
C07C 275/38^(2006.01)

C07C 275/30^(2006.01)
C07C 275/36^(2006.01)

(52)	Cooperative Patent Classification (CPC):
	A01N 47/30; A61K 31/17; A61K 31/235; A61K 31/36; A61K 31/44; A61K 31/4427; A61P 31/04; C07D 317/66

(86)	International application number:
	PCT/EP2017/063014

(87)	International publication number:
	WO 2017/207556 (07.12.2017 Gazette 2017/49)

(54)	UREA MOTIF CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS ANTIBACTERIAL DRUGS HARNSTOFFMOTIVHALTIGE VERBINDUNGEN UND DERIVATE DAVON ALS ANTIBAKTERIELLE WIRKSTOFFE MOTIF D'URÉE CONTENANT DES COMPOSÉS ET LEURS DÉRIVÉS EN TANT QU'AGENTS ANTIBACTÉRIENS

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

30.05.2016 EP 16171906

(43)	Date of publication of application:
	10.04.2019 Bulletin 2019/15

(73)	Proprietor: Technische Universität München
	80333 München (DE)

(72)	Inventors:
	LE, Philipp 80339 München (DE) SIEBER, Stephan 86919 Utting am Ammersee (DE) KUNOLD, Elena 174 49 Sundbyberg (SE)

(74)	Representative: Engelhard, Markus
	Boehmert & Boehmert Anwaltspartnerschaft mbB Pettenkoferstrasse 22 80336 München 80336 München (DE)

(56)

References cited: :

WO-A1-2014/089226
WO-A2-2010/123591

WO-A2-00/32196
KR-A- 20030 080 509

HAN-CHU CHANG ET. AL.: "In vitro and in vivo activity of a novel sorafenib derivative SC5005 against MRSA", JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, vol. 71, no. 2, 8 November 2015 (2015-11-08), pages 449-459, XP002760421, DOI: 10.1093/jac/dkv367
K. PANDURANGAN ET. AL.: "Supramolecular pyridyl urea gels as soft matter with antibacterial properties against MRSA and /or E.coli", CHEMICAL COMMUNICATIONS, vol. 50, 25 January 2014 (2014-01-25), pages 10819-10822, XP002760422, DOI: 10.1039/c4cc04028g
G. D. FRANSISCO ET. AL.: "Phenyl thiazolyl urea and carbamate derivatives as new inhibitors of bacterial cell-wall biosynthesis.", BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS, vol. 14, 5 January 2004 (2004-01-05), pages 235-238, XP002760423, DOI: 10.1016/j.bcml-2003.09.082
S-R CHOI ET. AL.: "Development of potential broad spectrum antimicrobials using C2-symmetric 9-fluorenone alkyl amine.", BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS, vol. 26, 2 March 2016 (2016-03-02), pages 1997-1999, XP002760424, DOI: 10.1016/j.bcml.20916.02.087

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).